Oxford BioMedica pauses some trials after finding potential impurities
(Reuters) - Gene-based biopharmaceutical company Oxford BioMedica said it put some of its trials on hold, after the company detected very low concentrations of potential impurities in a raw material.
No comments:
Post a Comment